[1]
“Effects of SGLT2 inhibitors on hemoglobin levels in patients with chronic kidney disease: A bibliographic review”, Rev Med Trujillo, vol. 19, no. 3, pp. 098–102, Sep. 2024, doi: 10.17268/rmt.2024.v19i3.6142.